化合物UC-781 T29037
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 178870-32-1 | ¥9,870.00 | 询底价 |
25 mg | 178870-32-1 | ¥7,680.00 | 询底价 |
1 mg | 178870-32-1 | ¥1,330.00 | 询底价 |
Product Introduction
Bioactivity
英文名: UC-781
描述: UC-781 (NSC-675186) 是一种高效且具有选择性的人类免疫缺陷病毒 HIV-1 非核苷类逆转录酶(NNRTI)I抑制剂 ,C50 值为 5 nM。UC-781 具有抗病毒活性和耐药性。UC-781状态稳定,较低的 PH 或不同温度对其影响较小。
体外活性: UC-781 (0.05, 0.2, and 0.5 % UC-781 supplemented gel; 10 days) is released from the gel formulation and clears HIV-1 from CEM cells [1].UC-781 (3.75 -30 μM) inhibits the growth of Bacillus cereus (approximately 50%).[1] UC-781 inhibits HIV-1 (IIIB) activity in CEM T cells (EC50=6 nM; IC50=23 nM). UC-781 inhibits HIV activity in monocyte-derived dendritic cells (MO-DCs) and autologous CD4+ T cells with EC50 values of 550 nM and 1588 nM, respectively.[2] UC-781 (1000 nM; 24 h) effectively prevents or blocks HIV infection of monocyte-derived dendritic cells and autologous CD4+ T cells.[2] UC-781 (0.001-1000 µM; 2 h) inhibits viral transfer and infection of cervical explants with HIV-1BaL.[4]
体内活性: UC-781(每日一次,连续10天,经阴道给予100 µl 5% UC-781增强凝胶;雌性兔)从凝胶制剂中释放,对雌性兔正常组织显示出低毒性,且不显著增加炎症细胞。[1]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
关键字: NSC675186 | UC-781 | NSC-675186
相关产品: SHEN26 | Epirengynic acid | Cephalotaxine | Valganciclovir hydrochloride | 2-PADQZ hydrochloride | β-Anomer | Methylthiouracil | (R,1R)-Tenofovir amibufenamide | Somantadine | Tizoxanide
相关库: Drug Repurposing Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Anti-Viral Compound Library | Bioactive Compound Library
化合物UC-781 T29037信息由TargetMol中国为您提供,如您想了解更多关于化合物UC-781 T29037报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途